Drug Deal Is Bet Price Pressures Have Eased

Wall Street Journal - 9 Jan 2017 19:34

Takeda Pharmaceutical's proposed acquisition of Ariad Pharmaceuticals for about $4.7 billion could boost valuations as buyers regain confidence in ability to raise prices.